168 related articles for article (PubMed ID: 3124801)
1. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
Rootman DS; Hobden JA; Jantzen JA; Gonzalez JR; O'Callaghan RJ; Hill JM
Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
[TBL] [Abstract][Full Text] [Related]
2. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
Hobden JA; O'Callaghan RJ; Hill JM; Reidy JJ; Rootman DS; Thompson HW
Curr Eye Res; 1989 Nov; 8(11):1163-9. PubMed ID: 2515036
[TBL] [Abstract][Full Text] [Related]
3. Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.
Hobden JA; Rootman DS; O'Callaghan RJ; Hill JM
Antimicrob Agents Chemother; 1988 Jul; 32(7):978-81. PubMed ID: 3142344
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
Hobden JA; Reidy JJ; O'Callaghan RJ; Hill JM; Insler MS; Rootman DS
Arch Ophthalmol; 1988 Nov; 106(11):1605-7. PubMed ID: 3142450
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.
Assil KK; Zarnegar SR; Fouraker BD; Schanzlin DJ
Am J Ophthalmol; 1992 Apr; 113(4):418-23. PubMed ID: 1558116
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Reidy JJ; Hobden JA; Hill JM; Forman K; O'Callaghan RJ
Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
[TBL] [Abstract][Full Text] [Related]
7. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
8. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Lauffenburger MD; Cohen KL
Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
[TBL] [Abstract][Full Text] [Related]
10. Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
Frucht-Perry J; Assil KK; Ziegler E; Douglas H; Brown SI; Schanzlin DJ; Weinreb RN
Cornea; 1992 Sep; 11(5):393-7. PubMed ID: 1424666
[TBL] [Abstract][Full Text] [Related]
11. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
Assil KK; Frucht-Perry J; Ziegler E; Schanzlin DJ; Schneiderman T; Weinreb RN
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3216-20. PubMed ID: 1748553
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
Callegan MC; Engel LS; Clinch TE; Hill JM; Kaufman HE; O'Callaghan RJ
Curr Eye Res; 1994 Dec; 13(12):875-8. PubMed ID: 7720394
[TBL] [Abstract][Full Text] [Related]
13. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of topical antibiotic on untreated eye in experimental keratitis.
Davis SD; Sarff LD; Hyndiuk RA
Can J Ophthalmol; 1978 Oct; 13(4):273-6. PubMed ID: 105787
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels.
Frucht-Pery J; Raiskup F; Mechoulam H; Shapiro M; Eljarrat-Binstock E; Domb A
Cornea; 2006 Dec; 25(10):1182-6. PubMed ID: 17172895
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.
Hobden JA; Reidy JJ; O'Callaghan RJ; Insler MS; Hill JM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1940-4. PubMed ID: 2210988
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic considerations in the treatment of bacterial keratitis.
Callegan MC; O'Callaghan RJ; Hill JM
Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
[TBL] [Abstract][Full Text] [Related]
20. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
